21 May 2013
Keywords: Roche, Galapagos, AnaptysBio, COPD, Antibodies, Licensing,
Article | 12 January 2010
Mechelen, Belgium-based Galapagos NV has entered into a global, multi-year strategic alliance with Swiss drug major Roche to develop potential ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 January 2010
12 January 2010
20 May 2013
© 2013 thepharmaletter.com